Triple-Hormone-Receptor Agonist Retatrutide for Obesity Phase 2 Trial
While it is effective in helping people lose weight initially, its effects may decrease over time, and using it long-term could lead to certain health risks
Accessed 20 Apr 2017 Stanley CA, Bennett MJ, Longo N (2014) Plasma membrane carnitine transporter defect, In: Valle D, Beaudet AL, Vogelstein B, Kinzler KW, Antonarakis SE, Ballabio A, Gibson K, Mitchell G (eds) The online metabolic and molecular bases of inherited disease New York, McGraw-Hill, New York
The GLP-1 in Ozempic is called semaglutide, and given its off-label popularity, drug manufacturers have now re-dosed semaglutide specifically for weight loss